Biomarin Pharmaceutical Inc. logo

Biomarin Pharmaceutical Inc. (0HNC)

Market Closed
24 Feb, 15:30
$
62. 58
-1.39
-2.17%
$
- Market Cap
126.18 P/E Ratio
- Div Yield
7,558 Volume
1 Eps
$ 63.97
Previous Close
Day Range
59.63 65.91
Year Range
59.63 99.65
Want to track 0HNC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0HNC earnings report is expected in 64 days (29 Apr 2026)
Name Time Cons. EPS Eps
Biomarin Pharmaceutical Inc. logo
0HNC Biomarin Pharmaceutical Inc.
29 Apr 2026 (In 2 months)
-
-
Biomarin Pharmaceutical Inc. logo
0HNC Biomarin Pharmaceutical Inc.
23 Feb 2026
0.56
-
Biomarin Pharmaceutical Inc. logo
0HNC Biomarin Pharmaceutical Inc.
19 Feb 2026
0.67
-
Biomarin Pharmaceutical Inc. logo
0HNC Biomarin Pharmaceutical Inc.
17 Feb 2026
-
-
Biomarin Pharmaceutical Inc. logo
0HNC Biomarin Pharmaceutical Inc.
27 Oct 2025
-
-
Biomarin Pharmaceutical Inc. logo
0HNC Biomarin Pharmaceutical Inc.
4 Aug 2025
-
-

0HNC Earnings Reports FAQ

What is the earnings per share (EPS) for 0HNC?

The current EPS is 1.

What is the company's earnings growth rate?

Biomarin Pharmaceutical Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-04-29, based on the 0HNC's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Biomarin Pharmaceutical Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0HNC at this time, as Biomarin Pharmaceutical Inc has no recent EPS data to calculate it.